Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients (Q44204313)

30 November 2017

Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients (English)

1 reference

30 November 2017

0 references

7

1 reference

30 November 2017

Biagio R Di Iorio

1

1 reference

30 November 2017

Vincenzo Bellizzi

2

1 reference

30 November 2017

Antonio Bellasi

3

1 reference

30 November 2017

Serena Torraca

4

1 reference

30 November 2017

Graziella D'Arrigo

5

1 reference

30 November 2017

Giovanni Tripepi

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

19 November 2012

1 reference

Nephrology Dialysis Transplantation

30 November 2017

1 reference

30 November 2017

28

1 reference

30 November 2017

632-640

1 reference

30 November 2017

3

1 reference

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

30 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Preservation of function in experimental renal disease by dietary restriction of phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Vegan supplemented diet in nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Assessment of nutritional practice in Italian chronic kidney disease clinics: a questionnaire-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

FGF23 induces left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Relationship between circulating FGF23 and total body atherosclerosis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Clinical relevance of FGF-23 in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Dietary phosphorus acutely impairs endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Nutrition and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Phosphorus and nutrition in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Pathophysiology of Progressive Nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS477

21 January 2018

Identifiers

DOI

10.1093/NDT/GFS477

1 reference

release_ii7yrfrxhfh7plwm7awti6lnmi

30 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ii7yrfrxhfh7plwm7awti6lnmi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference